| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/07/2013 | WO2013018883A1 Cancer treatment and/or prevention drug composition |
| 02/07/2013 | WO2013018882A1 Fusion gene of kif5b gene and ret gene, and method for determining effectiveness of cancer treatment targeting fusion gene |
| 02/07/2013 | WO2013018829A1 Method for treating cancer by combined use of medicinal agents |
| 02/07/2013 | WO2013018804A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | WO2013018733A1 1,5-naphthyridine derivative or salt thereof |
| 02/07/2013 | WO2013018695A1 Heterocyclic compound |
| 02/07/2013 | WO2013018690A1 Erap1-derived peptide and use thereof |
| 02/07/2013 | WO2013018096A1 Use of integrase for targeted gene expression |
| 02/07/2013 | WO2013018018A1 Antitumour combination comprising ombrabulin and cetuximab, associated with radiotherapy |
| 02/07/2013 | WO2013018017A1 Antitumour combination comprising ombrabulin and cisplatin, associated with radiotherapy |
| 02/07/2013 | WO2013018008A1 Basic alpha lipoic acid solution and its uses |
| 02/07/2013 | WO2013017989A1 Crizotinib for use in the treatment of cancer |
| 02/07/2013 | WO2013017977A1 Compositions and methods for the treatment of cancer |
| 02/07/2013 | WO2013017724A1 Use of a combination of azathioprine and l-buthionine-[s,r]-sulfoximine in the preparation of a drug useful in the treatment of a refractory tumor |
| 02/07/2013 | WO2013017637A1 Selective inhibition of malt1 protease by phenothiazine derivatives |
| 02/07/2013 | WO2013017600A1 Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one |
| 02/07/2013 | WO2013017548A1 1,4-diaryl-2-azetidinones with anti-tumoral activity |
| 02/07/2013 | WO2013017540A1 Combination therapy for the treatment of cd19+ b-cell malignancies symptoms comprising an anti-cd19 maytansinoid immunoconjugate and rituximab |
| 02/07/2013 | WO2013017494A1 Pharmaceutical composition of oxidised avidin suitable for inhalation |
| 02/07/2013 | WO2013017480A1 Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors |
| 02/07/2013 | WO2013017479A1 Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors |
| 02/07/2013 | WO2013017461A1 Pyridin-2(1h)-one derivatives as jak inhibitors |
| 02/07/2013 | WO2013017100A1 Imatinib mesylate tablet |
| 02/07/2013 | WO2013017073A1 Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament |
| 02/07/2013 | WO2013016999A1 Heteroaryl-pyrimidine derivatives, and preparation method therefor and use thereof |
| 02/07/2013 | WO2013016896A1 Agrocybe aegerita lectin aal-2, and encoding gene thereof, preparation method therefor and application thereof |
| 02/07/2013 | WO2013016754A1 Method and formulation for inhalation |
| 02/07/2013 | WO2012169822A9 Fusion protein for suppressing cancer cell growth and suppressing vasculogenesis, and anticancer composition comprising same |
| 02/07/2013 | WO2012165815A3 Nano-vehicle derived from tumor tissue, and cancer vaccine using same |
| 02/07/2013 | WO2012145575A3 Therapy for leukemia |
| 02/07/2013 | WO2012143713A3 Radioactive solutions for treating cancer |
| 02/07/2013 | WO2011106297A3 Compositions and methods for the diagnosis and treatment of tumor |
| 02/07/2013 | WO2011085063A9 Immune modulators relating to foxo3a |
| 02/07/2013 | US20130035754 Drug-delivery endovascular stent and method of forming the same |
| 02/07/2013 | US20130035404 Integrated Analyses of Breast and Colorectal Cancers |
| 02/07/2013 | US20130035394 Calixarene-Based Peptide Conformation Mimetics, Methods of Use, and Methods of Making |
| 02/07/2013 | US20130035386 Bis[thiohydrazide amide] compounds for treating leukemia |
| 02/07/2013 | US20130035379 Compositions for Inhibiting Protine-Directed Protein Kinase Fa/Glycogen Synthesis Kinase 3 Alpha and Use Thereof |
| 02/07/2013 | US20130035377 Tranylcypromine derivatives as inhibitors of histone demethylases lsd1 and/or lsd2 |
| 02/07/2013 | US20130035369 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 02/07/2013 | US20130035364 Benzylidene-indolinone compounds and their medical use |
| 02/07/2013 | US20130035363 Thalidomide Analogs |
| 02/07/2013 | US20130035360 Novel water soluble furoxan derivatives having antitumor activity |
| 02/07/2013 | US20130035350 Novel Quinazoline Derivatives |
| 02/07/2013 | US20130035349 Pyrazolopyrimidinone kinase inhibitor |
| 02/07/2013 | US20130035348 Antimetastatic compounds |
| 02/07/2013 | US20130035347 Aromatic bycyclic derivatives as cxcr4 receptor modulators |
| 02/07/2013 | US20130035343 Combination of organic compounds |
| 02/07/2013 | US20130035337 Fused bicyclic heteroaryl derivative |
| 02/07/2013 | US20130035336 Combination comprising a cyclin dependent kinase 4 or cyclin dependent kinase (cdk4/6) inhibitor for treating cancer |
| 02/07/2013 | US20130035335 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 02/07/2013 | US20130035334 Inhibitors of bruton's tyrosine kinase |
| 02/07/2013 | US20130035331 Thiazole and oxazole kinase inhibitors |
| 02/07/2013 | US20130035329 Therapeutically active compositions and their methods of use |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130035326 Biaryl compounds and methods of use thereof |
| 02/07/2013 | US20130035325 Kinase inhibitors |
| 02/07/2013 | US20130035324 Heterocyclic compounds and uses thereof |
| 02/07/2013 | US20130035322 Gold complexes |
| 02/07/2013 | US20130035321 Compounds for the treatment of ocular cancer |
| 02/07/2013 | US20130035317 Di-Aspirin Derivatives |
| 02/07/2013 | US20130035315 Crystallization method and bioavailability |
| 02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
| 02/07/2013 | US20130035311 Prochelators for inhibiting metal-promoted oxidative stress |
| 02/07/2013 | US20130035307 Methods for treating or preventing the spread of cancer using semi-synthetic glycosaminoglycosan ethers |
| 02/07/2013 | US20130035306 Process for preparing purine nucleosides |
| 02/07/2013 | US20130035305 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases |
| 02/07/2013 | US20130035304 Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders |
| 02/07/2013 | US20130035301 Cdc7 kinase inhibitors and uses thereof |
| 02/07/2013 | US20130035300 Method of using pomegranate extracts for increasing prostate specific antigen doubling time |
| 02/07/2013 | US20130035296 Therapeutic peptides |
| 02/07/2013 | US20130035295 Use of Peptide Epoxyketones for Metastasis Suppression |
| 02/07/2013 | US20130035286 Pharmaceutical Composition Comprising Cyclic Somatostatin Analogues |
| 02/07/2013 | US20130035260 Genes involved in inflammatory bowel diseases and use thereof |
| 02/07/2013 | US20130034617 Gallium compositions for the treatment of liver cancer and methods of use |
| 02/07/2013 | US20130034616 Compounds useful as inhibitors of atr kinase |
| 02/07/2013 | US20130034610 Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells |
| 02/07/2013 | US20130034608 Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents |
| 02/07/2013 | US20130034599 Synthetic nanostructures including nucleic acids and/or other entities |
| 02/07/2013 | US20130034598 Inhibitors of akt/pkb with anti-tumor activity |
| 02/07/2013 | US20130034591 Novel compounds and compositions for targeting cancer stem cells |
| 02/07/2013 | US20130034586 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response |
| 02/07/2013 | US20130034584 Agent for use in the topical or local treatment of cervical dysplasias |
| 02/07/2013 | US20130034574 Modified melk peptides and vaccines containing the same |
| 02/07/2013 | US20130034573 Vaccine compositions |
| 02/07/2013 | US20130034570 Methods and compositions for modulating prostasin |
| 02/07/2013 | US20130034566 Anti-cdh3 antibodies and uses thereof |
| 02/07/2013 | US20130034565 MOLECULES AND METHODS OF USING SAME FOR TREATING ErbB/ErbB LIGANDS ASSOCIATED DISEASES |
| 02/07/2013 | US20130034562 Selective androgen receptor modulators for treating diabetes |
| 02/07/2013 | US20130034559 Targeted Binding Agents Against B7-H1 |
| 02/07/2013 | US20130034558 Epidermal growth factor receptor variant |
| 02/07/2013 | US20130034557 Cancer-Related Glycopeptide Epitopes, Antibodies And Methods Of Use |
| 02/07/2013 | US20130034554 Antibodies to il-6 and use thereof |
| 02/07/2013 | US20130034551 Wnt Antagonists and Methods of Treatment and Screening |
| 02/07/2013 | US20130034549 Combination therapy for treating breast cancer |
| 02/07/2013 | US20130034548 Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers |
| 02/07/2013 | US20130034546 Analyzing Copy Number Variation in the Detection of Cancer |
| 02/07/2013 | US20130034543 Modulating xrn1 |
| 02/07/2013 | US20130034540 Immune Gene Signatures in Cancer |
| 02/07/2013 | US20130034539 Sr-bi as a predictor of human female infertility and responsiveness to treatment |